<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38549752</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-861X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in nutrition</Title><ISOAbbreviation>Front Nutr</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 condition: systemic inflammation and low functional exercise capacity.</ArticleTitle><Pagination><StartPage>1295026</StartPage><MedlinePgn>1295026</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1295026</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnut.2024.1295026</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Post-COVID-19 condition (PCC) is characterised by a plethora of symptoms, with fatigue appearing as the most frequently reported. The alterations that drive both the persistent and post-acute disease newly acquired symptoms are not yet fully described. Given the lack of robust knowledge regarding the mechanisms of PCC we have examined the impact of inflammation in PCC, by evaluating serum cytokine profile and its potential involvement in inducing the different symptoms reported.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this cross-sectional study, we recruited 227 participants who were hospitalised with acute COVID-19 in 2020 and came back for a follow-up assessment 6-12&#x2009;months after hospital discharge. The participants were enrolled in two symptomatic groups: Self-Reported Symptoms group (SR, <i>n</i>&#x2009;=&#x2009;96), who did not present major organ lesions, yet reported several debilitating symptoms such as fatigue, muscle weakness, and persistent loss of sense of smell and taste; and the Self-Reported Symptoms and decreased Pulmonary Function group (SRPF, <i>n</i>&#x2009;=&#x2009;54), composed by individuals with the same symptoms described by SR, plus diagnosed pulmonary lesions. A Control group (<i>n</i>&#x2009;=&#x2009;77), with participants with minor complaints following acute COVID-19, was also included in the study. Serum cytokine levels, symptom questionnaires, physical performance tests and general clinical data were obtained in the follow-up assessment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">SRPF presented lower IL-4 concentration compared with Control (<i>q&#x2009;=</i> 0.0018) and with SR (<i>q&#x2009;=</i> 0.030), and lower IFN-&#x3b1;2 serum content compared with Control (<i>q</i>&#x2009;=&#x2009;0.007). In addition, SRPF presented higher MIP-1&#x3b2; serum concentration compared with SR (<i>q&#x2009;=</i> 0.029). SR presented lower CCL11 (<i>q&#x2009;=</i> 0.012 and <i>q&#x2009;=</i> 0.001, respectively) and MCP-1 levels (<i>q&#x2009;=</i> 0.052 for both) compared with Control and SRPF. SRPF presented lower G-CSF compared to Control (<i>q</i>&#x2009;=&#x2009;0.014). Female participants in SR showed lower handgrip strength in relation to SRPF (<i>q&#x2009;=</i> 0.0082). Male participants in SR and SRPF needed more time to complete the timed up-and-go test, as compared with men in the Control group (<i>q&#x2009;=</i> 0.0302 and <i>q&#x2009;=</i> 0.0078, respectively). Our results indicate that different PCC symptom profiles are accompanied by distinct inflammatory markers in the circulation. Of particular concern are the lower muscle function findings, with likely long-lasting consequences for health and quality of life, found for both PCC phenotypes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 de Castro, Gama, Ramos, Gatti da Silva, Teixeira, Cunha-Neto, de Souza, Marie, Talib, Coelho, Kalil, de Araujo, Ritto, Belon, Santos, Barr&#xe9;re, Sawamura, Lamas, Baldi, Carvalho, Kulikowski, Damiano, Imamura, Rosa Neto, Lira, Otoch, Miguel, Battistella, Forlenza, Busatto and Seelaender.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Castro</LastName><ForeName>Gabriela Salim</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama</LastName><ForeName>Leonardo R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Centro de Pesquisa Translacional em Oncologia, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Alexandre Ferreira</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Centro de Pesquisa Translacional em Oncologia, Instituto do C&#xe2;ncer do Estado de S&#xe3;o Paulo, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escola de Artes, Ci&#xea;ncias e Humanidades, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatti da Silva</LastName><ForeName>Guilherme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira</LastName><ForeName>Alexandre Abilio de Souza</ForeName><Initials>AAS</Initials><AffiliationInfo><Affiliation>Instituto de Ciencias Biomedicas, Departamento de Biologia Celular e do Desenvolvimento, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunha-Neto</LastName><ForeName>Edecio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Cl&#xed;nica M&#xe9;dica, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o em Imunologia, Instituto Nacional de Ci&#xea;ncia e Tecnologia (III-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Heraldo Possolo</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Departamento de Emerg&#xea;ncias M&#xe9;dicas, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marie</LastName><ForeName>Suely K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talib</LastName><ForeName>Leda L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Laboratorio de Citogenomica, Departamento de Patologia, Faculdade de Medicina da Universidade de S&#xe3;o Paulo (FMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coelho</LastName><ForeName>Ver&#xf4;nica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o em Imunologia, Instituto Nacional de Ci&#xea;ncia e Tecnologia (III-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalil</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto de Investiga&#xe7;&#xe3;o em Imunologia, Instituto Nacional de Ci&#xea;ncia e Tecnologia (III-INCT), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunologia, Instituto do Cora&#xe7;&#xe3;o, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Araujo</LastName><ForeName>Adriana Ladeira</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Diretoria Executiva dos LIMs, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritto</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Diretoria Executiva dos LIMs, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Inova&#xe7;&#xe3;o InovaHC do Hospital das Cl&#xed;nicas HCFMUSP, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belon</LastName><ForeName>Alessandro Rodrigo</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Amanda Soares</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barr&#xe9;re</LastName><ForeName>Ana Paula Noronha</ForeName><Initials>APN</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawamura</LastName><ForeName>M&#xe1;rcio V Y</ForeName><Initials>MVY</Initials><AffiliationInfo><Affiliation>Instituto de Radiologia (InRad), Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamas</LastName><ForeName>Celina Almeida</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Divis&#xe3;o de Pneumologia do Instituto do Cora&#xe7;&#xe3;o (InCor), Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldi</LastName><ForeName>Bruno Guedes</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Divis&#xe3;o de Pneumologia do Instituto do Cora&#xe7;&#xe3;o (InCor), Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Carlos R R</ForeName><Initials>CRR</Initials><AffiliationInfo><Affiliation>Divis&#xe3;o de Pneumologia do Instituto do Cora&#xe7;&#xe3;o (InCor), Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo (HCFMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulikowski</LastName><ForeName>Leslie Domenici</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Laboratorio de Citogenomica, Departamento de Patologia, Faculdade de Medicina da Universidade de S&#xe3;o Paulo (FMUSP), S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damiano</LastName><ForeName>Rodolfo Furlan</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo HCFMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imamura</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departamento de Medicina Legal, Bioetica, Medicina do Trabalho e Medicina Fisica e Reabilitacao, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa Neto</LastName><ForeName>Jos&#xe9; Cesar</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Instituto de Ciencias Biomedicas, Departamento de Biologia Celular e do Desenvolvimento, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lira</LastName><ForeName>Fabio S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Exercise and Immunometabolism Research Group, Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias do Movimento, Departamento de Educa&#xe7;&#xe3;o F&#xed;sica, Faculdade de Ci&#xea;ncias e Tecnologia, Universidade Estadual Paulista (UNESP), Presidente Prudente, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otoch</LastName><ForeName>Jos&#xe9; Pinhata</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital Universitario, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miguel</LastName><ForeName>Euripedes Constantino</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Universidade de S&#xe3;o Paulo FMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battistella</LastName><ForeName>Linamara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Fisica e Reabilitacao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forlenza</LastName><ForeName>Orestes V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo HCFMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busatto</LastName><ForeName>Geraldo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Diretoria Executiva dos LIMs, Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento e Instituto de Psiquiatria, Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo HCFMUSP, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seelaender</LastName><ForeName>Marilia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cancer Metabolism Research Group, Departamento de Cirurgia and LIM 26-HC da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nutr</MedlineTA><NlmUniqueID>101642264</NlmUniqueID><ISSNLinking>2296-861X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38549752</ArticleId><ArticleId IdType="pmc">PMC10973152</ArticleId><ArticleId IdType="doi">10.3389/fnut.2024.1295026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S, Williams MA. Confronting our next National Health Disaster &#x2014; Long-haul Covid. N Engl J Med. (2021) 385:577&#x2013;579. doi: 10.1056/NEJMp2109285</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2109285</ArticleId><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. . Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis. J Med Virol. (2022) 94:253&#x2013;62. doi: 10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. (2020) 130:2620&#x2013;9. doi: 10.1172/JCI137244, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. (2020) 46:846&#x2013;8. doi: 10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins RB, Raymond SL, Stortz JA, Horiguchi H, Brakenridge SC, Gardner A, et al. . Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome. Front Immunol. (2018) 9:1511. doi: 10.3389/fimmu.2018.01511, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01511</ArticleId><ArticleId IdType="pmc">PMC6036179</ArticleId><ArticleId IdType="pubmed">30013565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanova M, Kohout P. Molecular mechanisms underlying intensive care unit-acquired weakness and sarcopenia. Int J Mol Sci. (2022) 23:396. doi: 10.3390/ijms23158396, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158396</ArticleId><ArticleId IdType="pmc">PMC9368893</ArticleId><ArticleId IdType="pubmed">35955530</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuna-Padilla IA, Hern&#xe1;ndez-C&#xe1;rdenas CM, Rodr&#xed;guez-Moguel NC, Rodr&#xed;guez-Llamazares S, Prado CM, R&#xed;os-Ayala MA, et al. . Low muscle mass in COVID-19 critically-ill patients: prognostic significance and surrogate markers for assessment. Clin Nutr. (2022) 41:3133. doi: 10.1016/j.clnu.2022.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2022.06.002</ArticleId><ArticleId IdType="pmc">PMC9167680</ArticleId><ArticleId IdType="pubmed">35768330</ArticleId></ArticleIdList></Reference><Reference><Citation>de Beltr&#xe3;o FEL, de Beltr&#xe3;o DCA, Carvalhal G, de Beltr&#xe3;o FNL, de Aquino IM, da Brito TS, et al. . Low muscle mass and high visceral fat mass predict mortality in patients hospitalized with moderate-to-severe COVID-19: a prospective study. Endocr Connect. (2022) 11:e220290. doi: 10.1530/EC-22-0290, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-22-0290</ArticleId><ArticleId IdType="pmc">PMC9578108</ArticleId><ArticleId IdType="pubmed">36040475</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S, de Oliveira J&#xfa;nior GN, Sarti FM, Filho WJ, Longobardi I, Turri JAO, et al. . Acute muscle mass loss predicts long-term fatigue, myalgia, and health care costs in COVID-19 survivors. J Am Med Dir Assoc. (2023) 24:10&#x2013;6. doi: 10.1016/j.jamda.2022.11.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2022.11.013</ArticleId><ArticleId IdType="pmc">PMC9682050</ArticleId><ArticleId IdType="pubmed">36493804</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al. . A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. med Rxiv. (2022) 1&#x2013;52. doi: 10.1101/2022.05.26.22275532</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon S, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. van Zon SKR, et al. . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. (2022) 400 (10350:452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, Mon&#xe1;rrez-Espino J, L&#xf3;pez DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. . The plasma metabolome of long COVID patients two years after infection. Sci Rep. (2023) 13:12420. doi: 10.1038/s41598-023-39049-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Rocca CCA, Serafim AP, Loftis JM, Talib LL, Pan PM, et al. . Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers. Front Immunol. (2023) 14:14. doi: 10.3389/fimmu.2023.1174020</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1174020</ArticleId><ArticleId IdType="pmc">PMC10242059</ArticleId><ArticleId IdType="pubmed">37287969</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, Araujo AL, Mauricio Castaldelli-Maia J, Damiano RF, Imamura M, Guedes BF, et al. . Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. Psychol Med. (2022), 52, 2387&#x2013;2398, doi: 10.1017/S0033291722001374</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722001374</ArticleId><ArticleId IdType="pmc">PMC9151630</ArticleId><ArticleId IdType="pubmed">35521752</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil S, Gualano B, de Ara&#xfa;jo AL, de Oliveira J&#xfa;nior GN, Damiano RF, Pinna F, et al. . Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Sci Rep. (2023) 13:215. doi: 10.1038/s41598-022-26888-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26888-3</ArticleId><ArticleId IdType="pmc">PMC9813883</ArticleId><ArticleId IdType="pubmed">36604523</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, de Ara&#xfa;jo AL, Duarte AJDS, Levin AS, Guedes BF, Kallas EG, et al. . Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in S&#xe3;o Paulo, Brazil. BMJ Open. (2021) 11:e051706. doi: 10.1136/bmjopen-2021-051706, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-051706</ArticleId><ArticleId IdType="pmc">PMC8249176</ArticleId><ArticleId IdType="pubmed">34193506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianna LC, Oliveira RB, Ara&#xfa;jo CGS. Age-related decline in handgrip strength differs according to gender. J Strength Cond Res. (2007) 21:1310&#x2013;4. doi: 10.1519/R-23156.1 PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1519/R-23156.1</ArticleId><ArticleId IdType="pubmed">18076278</ArticleId></ArticleIdList></Reference><Reference><Citation>McPherson RA, Pincus MR, Henry JB. Henry&#x2019;s clinical diagnosis and management by laboratory methods. 18&#xaa; edition, 1991 - W. B. Saunders Company Philadelphia, Pennsylvania, USA.</Citation></Reference><Reference><Citation>CLSI C44-A Harmonization Of Glycohemoglobin Measurements; Approved Guideline . (2002).</Citation></Reference><Reference><Citation>Rifai N, Horvath AR, Andrea R, Wittwer C, Tietz NW. Tietz fundamentals of clinical chemistry and molecular diagnostics. Champaign, IL: Human Kinetics Pub. Tieitz Textbook of Clinical Chemistry Carl A. burtis, Edwardr. Ashwood. Chapter 32 Hemoglobin, Iron and Bilirrubin. 2&#xaa; editions, 1994 - W. B. Saunders Company Philadelphia, Pennsylvania, USA.</Citation></Reference><Reference><Citation>R Core Team . R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Version 4.3 released in 2023.</Citation></Reference><Reference><Citation>Gao Y, Ding M, Dong X, Zhang J, Kursat Azkur A, Azkur D, et al. . Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. (2021) 76:428&#x2013;55. doi: 10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. (2009) 373:1798&#x2013;807. doi: 10.1016/S0140-6736(09)60553-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60553-5</ArticleId><ArticleId IdType="pmc">PMC3144755</ArticleId><ArticleId IdType="pubmed">19465235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie GW, Yi NZ, Hu Y, Hua LW, Quan OC, Xing HJ, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. (2020) 382:1708&#x2013;20. doi: 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. (2014) 105:141&#x2013;50. doi: 10.1016/j.diabres.2014.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2014.04.006</ArticleId><ArticleId IdType="pubmed">24798950</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D, S&#xe1;nchez-Serrano N, Mielgo-Ayuso J, Garc&#xed;a-Hern&#xe1;ndez JL, Gonz&#xe1;lez-Bernal JJ, Seco-Calvo J. Long COVID a new derivative in the chaos of SARS-CoV-2 infection: The emergent pandemic? J Clin Med. (2021) 10:5799. doi: 10.3390/jcm10245799, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245799</ArticleId><ArticleId IdType="pmc">PMC8708091</ArticleId><ArticleId IdType="pubmed">34945095</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. (2020) 369:718&#x2013;24. doi: 10.1126/science.abc6027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber G. The molecular basis for differential type I interferon signaling. J Biol Chem. (2017) 292:7285&#x2013;94. doi: 10.1074/jbc.R116.774562, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R116.774562</ArticleId><ArticleId IdType="pmc">PMC5418031</ArticleId><ArticleId IdType="pubmed">28289098</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli C, Abdelsalam A, D&#x2019;Addio F, Ben Nasr M, Assi E, Usuelli V, et al. . PD-1 blockade counteracts post&#x2013;COVID-19 immune abnormalities and stimulates the anti&#x2013;SARS-CoV-2 immune response. JCI Insight. (2021) 6:1&#x2013;13. doi: 10.1172/jci.insight.146701</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, Rodr&#xed;guez Y, Roa G, Lozano M, et al. . Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. (2021) 20:102947. doi: 10.1016/j.autrev.2021.102947, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodr&#xed;guez Y, Zapata E, Ram&#xed;rez-Santana C, et al. . Persistent autoimmune activation and Proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis. (2022) 225:2155&#x2013;62. doi: 10.1093/infdis/jiac017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. (2022) 3:100663. doi: 10.1016/j.xcrm.2022.100663, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. . Sex differences in immune responses that underlie COVID-19 disease outcomes. Nat Cell Biol. (2020) 588:315&#x2013;20. doi: 10.1038/s41586-020-2700-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelutti M, Furlanis G, Buoite Stella A, Bellavita G, Frezza N, Torresin G, et al. . Sex-dependent characteristics of neuro-long-COVID: data from a dedicated neurology ambulatory service. J Neurol Sci. (2022) 441:120355. doi: 10.1016/j.jns.2022.120355, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120355</ArticleId><ArticleId IdType="pmc">PMC9328838</ArticleId><ArticleId IdType="pubmed">35994869</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Neto DB, Oliveira JVR, Magalh&#xe3;es Santos J, Alves JVR, Guedes BF, et al. . Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. Eur Arch Psychiatry Clin Neurosci. (2022) 1:1&#x2013;9. doi: 10.1007/s00406-022-01427-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01427-3</ArticleId><ArticleId IdType="pmc">PMC9142732</ArticleId><ArticleId IdType="pubmed">35633395</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, et al. . The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. (2011) 477:90&#x2013;4. doi: 10.1038/nature10357, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10357</ArticleId><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. (2022) 185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Carniel BP, da Rocha NS. Brain-derived neurotrophic factor (BDNF) and inflammatory markers: perspectives for the management of depression. Prog Neuropsychopharmacol Biol Psychiatry. (2021) 108:110151. doi: 10.1016/j.pnpbp.2020.110151, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.110151</ArticleId><ArticleId IdType="pubmed">33096156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuipers SD, Trentani A, den Boer JA, ter Horst GJ. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem, Lond. (2003) 85:1312&#x2013;23. doi: 10.1046/j.1471-4159.2003.01770.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01770.x</ArticleId><ArticleId IdType="pubmed">12753089</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al. . Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. (2003) 54:70&#x2013;5. doi: 10.1016/S0006-3223(03)00181-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3223(03)00181-1</ArticleId><ArticleId IdType="pubmed">12842310</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans G, Van den Berghe G. Clinical review: Intensive care unit acquired weakness. Critical Care Bio Med Central Ltd. (2015) 19:274. doi: 10.1186/s13054-015-0993-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0993-7</ArticleId><ArticleId IdType="pmc">PMC4526175</ArticleId><ArticleId IdType="pubmed">26242743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto FCS, Andrade MF, Gatti da Silva GH, Faiad JZ, Barr&#xe9;re APN, Gon&#xe7;alves RC, et al. . Function over mass: a Meta-analysis on the importance of skeletal muscle quality in COVID-19 patients. Front Nutr. (2022) 9:679. doi: 10.3389/fnut.2022.837719</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.837719</ArticleId><ArticleId IdType="pmc">PMC9067541</ArticleId><ArticleId IdType="pubmed">35529467</ArticleId></ArticleIdList></Reference><Reference><Citation>Martone AM, Tosato M, Ciciarello F, Galluzzo V, Zazzara MB, Pais C, et al. . Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors. JCSM rapid communications. (2022) 13:1974&#x2013;82. doi: 10.1002/jcsm.12931, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12931</ArticleId><ArticleId IdType="pmc">PMC9349974</ArticleId><ArticleId IdType="pubmed">35698920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejb&#xf8;l EK, Harbo T, Agergaard J, Madsen LB, Pedersen TH, &#xd8;stergaard LJ, et al. . Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. (2022) 29:2832&#x2013;41. doi: 10.1111/ene.15435, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs JK, Huwe M, Hennigs A, Oqueka T, Simon M, Harbaum L, et al. . Respiratory muscle dysfunction in long-COVID patients. Infection. (2022) 50:1391&#x2013;7. doi: 10.1007/s15010-022-01840-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01840-9</ArticleId><ArticleId IdType="pmc">PMC9108020</ArticleId><ArticleId IdType="pubmed">35570238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D, Santamar&#xed;a G, S&#xe1;nchez-Serrano N, Lantar&#xf3;n Caeiro E, Seco-Calvo J. Efficacy of therapeutic exercise in reversing decreased strength, impaired respiratory function, decreased physical fitness, and decreased quality of life caused by the post-COVID-19 syndrome. Viruses. (2022) 14:2797. doi: 10.3390/v14122797, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122797</ArticleId><ArticleId IdType="pmc">PMC9784943</ArticleId><ArticleId IdType="pubmed">36560801</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung TW, Wong KS, Hui AC, To KF, Lai ST, Ng WF, et al. . Myopathic changes associated with severe acute respiratory syndrome. Arch Neurol. (2005) 62:1113&#x2013;7. doi: 10.1001/archneur.62.7.1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.7.1113</ArticleId><ArticleId IdType="pubmed">16009768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, et al. . The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol Clin Res. (2003) 200:282&#x2013;9. doi: 10.1002/path.1440, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1440</ArticleId><ArticleId IdType="pmc">PMC7168017</ArticleId><ArticleId IdType="pubmed">12845623</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, Tansey CM, Matt&#xe9; A, Tomlinson G, Diaz-Granados N, Cooper A, et al. . Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. (2011) 364:1293&#x2013;304. doi: 10.1056/NEJMoa1011802, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1011802</ArticleId><ArticleId IdType="pubmed">21470008</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, al-Saidi F, et al. . One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. (2003) 348:683&#x2013;93. doi: 10.1056/NEJMoa022450</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022450</ArticleId><ArticleId IdType="pubmed">12594312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KS, Mourtzakis M, Aronson Friedman L, Dinglas VD, Hough CL, Ely EW, et al. . Evaluating muscle mass in survivors of acute respiratory distress syndrome: a 1-year multicenter longitudinal study. Crit Care Med. (2018) 46:1238&#x2013;46. doi: 10.1097/CCM.0000000000003183, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003183</ArticleId><ArticleId IdType="pmc">PMC6051433</ArticleId><ArticleId IdType="pubmed">29727365</ArticleId></ArticleIdList></Reference><Reference><Citation>Auyeung TW, Lee JSW, Leung J, Kwok T, Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3, 153 older adults&#x2014;an alternative measurement of sarcopenia and sarcopenic obesity. Age (Omaha). (2013) 35:1377&#x2013;85. doi: 10.1007/s11357-012-9423-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-012-9423-9</ArticleId><ArticleId IdType="pmc">PMC3705102</ArticleId><ArticleId IdType="pubmed">22614096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding C, Chan Z, Magkos F. Lean, but not healthy: the &#x201c;metabolically obese, normal-weight&#x201d; phenotype. Curr Opin Clin Nutr Metab Care. (2016) 19:408&#x2013;17. doi: 10.1097/MCO.0000000000000317</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000317</ArticleId><ArticleId IdType="pubmed">27552473</ArticleId></ArticleIdList></Reference><Reference><Citation>Herminghaus A, Osuchowski MF. How sepsis parallels and differs from COVID-19. EBioMedicine. (2022) 86:104355. doi: 10.1016/j.ebiom.2022.104355, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104355</ArticleId><ArticleId IdType="pmc">PMC9718536</ArticleId><ArticleId IdType="pubmed">36470836</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine. (2020) 61:103044. doi: 10.1016/j.ebiom.2020.103044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103044</ArticleId><ArticleId IdType="pmc">PMC7544455</ArticleId><ArticleId IdType="pubmed">33039713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. (2023) 29:2347&#x2013;57. doi: 10.1038/s41591-023-02521-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R, Lyngdoh T, Kakkar AK. Deciphering the COVID-19 cytokine storm: systematic review and meta-analysis. Eur J Clin Invest. (2021) 51:e13429. doi: 10.1111/eci.13429, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13429</ArticleId><ArticleId IdType="pmc">PMC7646004</ArticleId><ArticleId IdType="pubmed">33058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. (2022) 23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. (2022) 375:1122&#x2013;7. doi: 10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>